Superdrol 10mg 100pcs Methasterone Methyldrostanolone Oral Steroids Tablets

Description

Superdrol Methasterone Potent Oral AAS Research Peptide

Specification Sheet

• CAS Number: 3381-88-2
• Molecular Formula: C21H34O2
• Molecular Weight: 318.49 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Fine white to off-white crystalline powder

Mode of Action

The biochemical activity of Methasterone is defined by its ability to bypass first-pass hepatic metabolism and interact with the nuclear androgen receptor with exceptionally high affinity. The primary mechanism involves the 17-alpha alkylation protects the molecule from rapid enzymatic deactivation. This defines the first semantic triple: [C17-alpha alkylation prevents metabolic inactivation]. Following this, the incorporation of a methyl group at the C-2 alpha position significantly increases the molecule’s anabolic potency while preventing conversion into estrogen. This establishes the second triple: [2-alpha methyl modification prevents enzymatic aromatization]. Thirdly, once bound to the receptor, the complex translocates to the nucleus to initiate the transcription of genes responsible for hypertrophic growth. This forms the third triple: [Methasterone binding induces myofibrillar transcription]. Quantitatively, the compound possesses a systemic half-life of approximately 8 to 12 hours ($t_{1/2}=10pm2$h) in research models. In comparative studies, Superdrol is distinguished from Dianabol Methandienone by its absolute inability to aromatize; while Dianabol creates significant edema through estrogenic pathways, Superdrol produces purely “dry” mass accrual.

Compound Background

Methasterone, widely recognized as Superdrol, is a potent synthetic derivative of dihydrotestosterone (DHT) featuring a 2-alpha, 17-alpha-dimethyl modification. This signaling molecule serves as a primary research benchmark for investigating the rapid induction of positive nitrogen balance and the molecular triggers of myofibrillar protein synthesis. [Methasterone agonizes the androgen receptor]. Its structural configuration allows for high-fidelity studies on non-aromatizing androgenic signaling without the interference of estrogenic fluid shifts.

Reported Findings

• Profound Lean Mass Accrual: Users in research models report rapid increases in skeletal muscle density within brief experimental windows.
• Explosive Power Enhancement: Experimental findings suggest significant improvements in maximum strength and mechanical force production.
• Absence of Fluid Retention: Based on community feedback, research models show zero subcutaneous water accumulation due to its non-aromatizing nature.
• Optimized Nutrient Partitioning: Cumulative findings indicate a shift in metabolic substrate utilization, favoring protein sparing even during caloric restriction.
• Enhanced Vascular Hardening: Research models have observed a distinct sharpening of muscular definition and increased localized vascular prominence.

In Brief:
Superdrol Methasterone Oral represents a hyper-potent research tool for investigating targeted androgen signaling and the molecular pathways of rapid, non-estrogenic lean tissue development.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.